French asset manager Amundi has largely cashed out of China’s September equity rally, reallocating more of its holdings to dividend stocks amid lingering doubts about the country’s economic outlook. The European firm, which manages €2.3 trillion (US$2.7 trillion) in assets, had trimmed positions in “overvalued” Chinese stocks while selectively increasing exposure to onshore shares over…
Toby Neugebauer, chief executive officer of Fermi Inc., before ringing the closing bell during the company’s Oct. 1 IPO. Victor J. Blue/Bloomberg Plenty of billionaires have been created by the artificial intelligence and data center booms—and now, the real estate underneath the data centers is generating ten-figure fortunes, too. At least three new billionaires joined…
In 2022, Elon Musk acquired Twitter, now known as X, stating it was to promote a “digital town square, where a wide range of beliefs can be debated in a healthy manner.” Upon his purchase, Musk loosened content moderation policies and reinstated many previously banned accounts, including that of President Donald Trump. In this excerpt…
The electric vehicle revolution is often framed as a climate imperative—a way to cut carbon emissions and slow global warming. But the race to electrify automotive fleets is not just about the transportation sector: EVs are the gateway to a new military-industrial era. And China is already winning. While the U.S. dithers over charging stations…
OpenAI is releasing a stand-alone social app for making and sharing artificial intelligence-generated videos with friends, an attempt to supercharge adoption for the emerging technology just as ChatGPT did for chatbots three years ago. The free Sora app, available from Tuesday by invitation, is powered by a new version of OpenAI’s video-making software of the…
Hong Kong has once again displayed its resilience. The city retained its No 3 ranking in the Global Financial Centres Index, just behind New York and London, while initial public offerings surged eightfold in the first half of 2025. For the first time since 2019, Hong Kong held the top spot in global IPO fundraising….
Biomap, a biotechnology start-up co-established by Baidu founder Robin Li Yanhong and backed by the Hong Kong government, says it has surpassed Alphabet subsidiary AlphaFold in commercialising artificial intelligence foundation models for drug discovery. Multinational pharmaceutical companies were seeing a “reverse” in the technological gap between Biomap and AlphaFold, Wei Liu, co-founder and CEO of…